申请人:Banyu Pharmaceuticals, Co., Ltd.
公开号:US07504412B2
公开(公告)日:2009-03-17
The invention provides imidazopyridine derivatives represented by the general formula [I] [in which R1 and R2 may be the same or different and stand for C1-6 alkyl or the like, R3 and R4 stand for hydrogen atom, methyl group or the like, W stands for mono- or bi-cyclic 3- to 8-membered aromatic or aliphatic heterocycle or the like, and Ar stands for optionally substituted aromatic heterocycle or the like]. These compounds act as melanin-concentrating hormone receptor antagonist and are useful as medicines for central nervous system disorders, cardiovascular system disorders and metabolic disorders.
本发明提供了由通式[I]表示的咪唑吡啶衍生物 [其中R1和R2可以相同或不同,代表C1-6烷基或类似物,R3和R4代表氢原子,甲基基团或类似物,W代表单环或双环3-8成员的芳香或脂肪族杂环或类似物,Ar代表可选取代的芳香杂环或类似物]。这些化合物作为黑素浓聚激素受体拮抗剂,并且可用于治疗中枢神经系统疾病、心血管系统疾病和代谢性疾病的药物。